WuXi Biologics Named to CDP Supplier Engagement Assessment A List for the Second Consecutive Year
AI disclosure
Summary
SHANGHAI, June 3, 2026 /PRNewswire/ -- WuXi Biologics (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), today ...